Liberum Capital restated their buy rating on shares of Genus (LON:GNS) in a research report report published on Friday morning, ThisIsMoney.Co.Uk reports.
A number of other brokerages also recently commented on GNS. Peel Hunt restated a buy rating on shares of Genus in a research note on Monday, March 25th. HSBC initiated coverage on Genus in a research note on Tuesday, February 12th. They issued a buy rating and a GBX 2,650 ($34.63) target price on the stock.
Shares of GNS opened at GBX 2,332 ($30.47) on Friday. Genus has a 52 week low of GBX 2,090 ($27.31) and a 52 week high of GBX 2,998 ($39.17). The company has a current ratio of 2.08, a quick ratio of 1.32 and a debt-to-equity ratio of 22.58. The stock has a market capitalization of $1.50 billion and a PE ratio of -215.93.
Genus plc operates as an animal genetics company in North America, Latin America, rest of Europe, the Middle East, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Research and Development. It sells sows, boars, and semen to breed pigs with various characteristics for pork production under the PIC brand.
Recommended Story: What does cost of debt say about a company’s financial health?
Receive News & Ratings for Genus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus and related companies with MarketBeat.com's FREE daily email newsletter.